-
Kanaph Therapeutics Closes 21M USD Series B Funding
prnasia
October 15, 2020
Kanaph Therapeutics, a leading biotech in oncology, auto-immune, and eye diseases with large molecules and small molecules, recently completed their Series B funding of 21M USD in South Korea.
-
Antengene, WuXi Biologics Ink Innovative Oncology R&D Alliance
contractpharma
October 14, 2020
Partner for the development and production of novel drugs, and to jointly promote R&D of innovative oncology therapies.
-
Pfizer and CStone to collaborate for oncology therapies in China
expresspharma
October 09, 2020
CStone to receive up to $280 million in milestone payments for sugemalimab, and additional royalties.
-
Bispecific antibodies will mature after 2021, $6bn estimated sales in oncology by 2025: GlobalData
expresspharma
October 09, 2020
There are 106 bispecific antibody molecules in the pipeline and 263 ongoing/planning to enrol clinical trials involving a bispecific antibody.
-
Accenture reveals data science project for paediatric leukaemia
pharmatimes
September 30, 2020
Accenture Applied Intelligence announced a new data and analytics approach to manage and derive insights from paediatric acute myeloid leukaemia (AML) genomic data, with the potential to improve precision medicine.
-
New Guidelines for Maximizing Cures and Minimizing Side Effects in Children with Hodgkin Lymphoma
prnasia
September 30, 2020
The National Comprehensive Cancer Network® (NCCN®) announced the publication of new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Pediatric Hodgkin Lymphoma.
-
MSD partners with Seattle Genetics on two new oncology projects
pharmatimes
September 16, 2020
MSD, known as Merck in the US and Canada, has announced two new oncology collaborations with biotech company and oncology specialist Seattle Genetics.
-
Lupin signs exclusive distribution deal with ForDoz Pharma for complex injectable assets
expresspharma
August 07, 2020
The two assets, which are in the oncology and anti-infective therapeutic areas, are under development in the US and its territories.
-
Thermo Fisher Expands GlobalAccess Program to Oncology Labs
americanpharmaceuticalreview
August 03, 2020
Thermo Fisher Scientific has announced the expansion of its GlobalAccess Sequencing Program to include laboratories working in oncology.
-
Merck Inks $425M Oncology Deal with Foghorn Therapeutics
contractpharma
July 09, 2020
To discover and develop novel oncology therapeutics against transcription factor target.